EXACT Sciences Corporation (EXAS) — Capital Reinvestment Ratio
Latest as of December 2025:
0.21x
EXACT Sciences Corporation (EXAS) has a Capital Reinvestment Ratio of 0.21x as of December 2025, meaning it reinvests 0% of its operating cash flow ($151.69 Million) in capital expenditures ($31.24 Million). See how much free cash does EXACT Sciences Corporation generate to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.21x
Capex / Operating Cash Flow
Operating Cash Flow
$151.69 Million
USD
Capital Expenditures
$31.24 Million
USD
Data as of
Dec 2025
Most recent filing
EXACT Sciences Corporation Capital Reinvestment Ratio (2020–2025)
This chart tracks EXACT Sciences Corporation's Capital Reinvestment Ratio across 4 annual periods.
Annual Capital Reinvestment Ratio for EXACT Sciences Corporation (2020–2025)
Year-by-year Capital Reinvestment Ratio for EXACT Sciences Corporation from 2020 to 2025. For live market cap and broader valuation context, see EXAS market cap overview.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.27x | $491.44 Million | $134.66 Million | ▼ -57.6% |
| 2024 | 0.65x | $210.54 Million | $135.99 Million | ▼ -18.8% |
| 2023 | 0.80x | $156.12 Million | $124.19 Million | ▲ +68.7% |
| 2020 | 0.47x | $136.48 Million | $64.35 Million | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow